Main market
Access this stock data via API
Subscribe
Mabpharm Ltd.
0
0
0%

Financials

Income statement

Fundamentals currency is CNY
Fiscal date 2024 2023 2022 2021
Total reported revenue 285.1M 96.2M 61.1M 82.9M
Cost of revenue 42.9M 13.2M 16.8M 16.8M
Gross profit 242.3M 83.1M 44.3M 66.1M
Operating expense
Research & development 83.0M 136.0M 161.6M 263.6M
Selling general and admin 199.3M 77.2M 54.8M 30.7M
Other operating expenses
Operating income -121.8M -218.9M -217.7M -284.7M
Non operating interest income
Income 566.4K 166.7K 417.4K 2.0M
Expense 11.7M 10.6M 7.9M 2.4M
Other income expense
Pretax income -141.3M -231.2M -230.3M -291.7M
Tax provision 0 0 0 0
Net income -141.3M -231.2M -230.3M -291.7M
Basic EPS 0.0 -0.1 -0.1 -0.1
Diluted EPS 0.0 -0.1 -0.1 -0.1
Basic average shares 4.6B 4.6B 4.5B 3.9B
Diluted average shares 4.6B 4.6B 4.5B 3.9B
EBITDA -60.1M -153.5M -166.4M -245.4M
Net income from continuing op. -141.3M -231.2M -230.3M -291.7M
Minority interests
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 5 hours 57 minutes

10:02
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
09:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 16:10
All times are displayed in the Asia/Hong_Kong timezone (HKT, UTC+08:00).